Congenital hypertrophy of the retinal pigment epithelium presenting with secondary choroidal neovascularization

Robert B. Garoon, J. William Harbour

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The authors report a case of a congenital hypertrophy of the retinal pigment epithelium (CHRPE) associated with choroidal neovascularization (CNV) causing symptomatic vision loss. Two intravitreal injections of bevacizumab (Avastin; Genentech, South San Francisco, CA) 4 weeks apart resolved the fluid and improved the visual acuity. This case demonstrates that CHRPE can rarely be complicated by CNV, which may respond to intravitreal bevacizumab therapy.

Original languageEnglish (US)
Pages (from-to)276-277
Number of pages2
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume49
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint Dive into the research topics of 'Congenital hypertrophy of the retinal pigment epithelium presenting with secondary choroidal neovascularization'. Together they form a unique fingerprint.

  • Cite this